Search
Close this search box.
    • Small Molecules
      • Discovery
        Development
        Manufacturing
    • Biologics
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers
Search
Close this search box.

Science in 3 minutes

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

Science in 3 Minutes: Targeted Protein Degradation

In this video, Dr. Tony Kurissery shares some insights into Targeted Protein Degradation and how Syngene has enabled clients working on PROTACs.

Science in 3 Minutes: Synthetic Peptides

In this video, Arunima Mukherjee from Syngene’s Discovery Chemistry team explains synthetic peptides, their applications, and how our team of scientists have enabled the generation of up to 50-mer linear peptides.

Science in 3 minutes: Bleomycin induced pulmonary fibrosis mouse model

In this video, Dr. Ramesh Subbarayan from Syngene’s Discovery Biology team explains the science behind Syngene’s bleomycin-induced pulmonary fibrosis mouse model that is helping advance research in pulmonary fibrosis.

Sign-up for our newsletter

© 2024. Syngene International Limited

Linkedin-in Youtube Facebook-f

Quick links

Business

Get in touch

Other links
Linkedin-in Youtube Facebook-f

© 2024. Syngene International Limited

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close

To view or email, Please share your details view

To download, Please share your details